BCG Vaccine Market to Grow at 3.3% CAGR Through 2032 According to a newly published market research report by 24LifeSciences, global Bacille Calmette-Guerin vaccine market was valued at USD 73.4 million in 2024 and is projected to reach USD 91.7 million by 2031, growing at a compound annual growth rate (CAGR) of 3.3% during the forecast period of 2025-2031. Bacille Calmette-Gurin (BCG) vaccine, a live-attenuated strain derived from Mycobacterium bovis, remains the world's most widely administered vaccine for tuberculosis prevention and stands as a cornerstone in global immunization programs. Its primary role involves protecting infants and young children in regions with high TB prevalence from severe forms of the disease, including military TB and TB meningitis. While its efficacy against pulmonary TB in adults shows limitations, its established protective benefits for pediatric populations ensure its continued relevance in public health strategies worldwide. Beyond TB prevention, the vaccine has gained significant therapeutic importance in oncology, particularly for the treatment of non-muscle-invasive bladder cancer, representing a vital secondary application that diversifies its market value. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3756/bacille-calmette-guerin-vaccine-market

Global Pertussis Vaccine Market to Grow at a CAGR of 3.8% by 2032 According to a newly published market research report by 24LifeSciences, global pertussis vaccine market was valued at USD 4,917 million in 2024 and is projected to reach USD 6,341 million by 2031, growing at a compound annual growth rate (CAGR) of 3.8% during the forecast period 2025-2031. Pertussis vaccines, which protect against whooping cough caused by the Bordetella pertussis bacterium, are critical components of global immunization programs. These vaccines are available as whole-cell (wP) and more commonly used acellular (aP) formulations, with the latter offering a refined safety profile. Their established role in preventing severe respiratory illness, particularly in vulnerable infant populations, continues to underpin their public health importance and drive consistent market demand across both pediatric and adult vaccination schedules. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7394/pertussis-vaccine-market